These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12510849)

  • 41. Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats.
    Torres TP; Catlin RL; Chan R; Fujimoto Y; Sasaki N; Printz RL; Newgard CB; Shiota M
    Diabetes; 2009 Jan; 58(1):78-86. PubMed ID: 18952838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The development of overt diabetes in young Zucker Diabetic Fatty (ZDF) rats and the effects of chronic MCC-555 treatment.
    Pickavance L; Widdowson PS; King P; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Oct; 125(4):767-70. PubMed ID: 9831913
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dangnyohwan improves glucose utilization and reduces insulin resistance by increasing the adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima Fatty rats.
    Park SY; Choi YH; Lee W
    J Ethnopharmacol; 2008 Feb; 115(3):473-82. PubMed ID: 18068920
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acute and chronic oral administration of bis(maltolato)oxovanadium(IV) in Zucker diabetic fatty (ZDF) rats.
    Yuen VG; Vera E; Battell ML; Li WM; McNeill JH
    Diabetes Res Clin Pract; 1999 Jan; 43(1):9-19. PubMed ID: 10199584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction in the Dietary VA Status Prevents Type 2 Diabetes and Obesity in Zucker Diabetic Fatty Rats.
    Wang T; Tang X; Hu X; Wang J; Chen G
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454117
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [6]-Gingerol, from Zingiber officinale, potentiates GLP-1 mediated glucose-stimulated insulin secretion pathway in pancreatic β-cells and increases RAB8/RAB10-regulated membrane presentation of GLUT4 transporters in skeletal muscle to improve hyperglycemia in Lepr
    Samad MB; Mohsin MNAB; Razu BA; Hossain MT; Mahzabeen S; Unnoor N; Muna IA; Akhter F; Kabir AU; Hannan JMA
    BMC Complement Altern Med; 2017 Aug; 17(1):395. PubMed ID: 28793909
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of Zucker diabetic fatty rats.
    MacDonald MJ; Tang J; Polonsky KS
    Diabetes; 1996 Nov; 45(11):1626-30. PubMed ID: 8866570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In Zucker diabetic fatty rats plasma leptin levels are correlated with plasma insulin levels rather than with body weight.
    Janssen SW; Martens GJ; Sweep CG; Ross HA; Hermus AR
    Horm Metab Res; 1999 Nov; 31(11):610-5. PubMed ID: 10598829
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats.
    Agil A; Rosado I; Ruiz R; Figueroa A; Zen N; Fernández-Vázquez G
    J Pineal Res; 2012 Mar; 52(2):203-10. PubMed ID: 21883445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of vanadium on insulin and leptin in Zucker diabetic fatty rats.
    Wang J; Yuen VG; McNeill JH
    Mol Cell Biochem; 2001 Feb; 218(1-2):93-6. PubMed ID: 11330843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats.
    Sudre B; Broqua P; White RB; Ashworth D; Evans DM; Haigh R; Junien JL; Aubert ML
    Diabetes; 2002 May; 51(5):1461-9. PubMed ID: 11978643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profiling of Zucker diabetic fatty rats in their progression to the overt diabetic state.
    Etgen GJ; Oldham BA
    Metabolism; 2000 May; 49(5):684-8. PubMed ID: 10831184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats.
    Castoldi G; di Gioia CRT; Roma F; Carletti R; Manzoni G; Stella A; Zerbini G; Perseghin G
    Acta Diabetol; 2019 Jan; 56(1):97-104. PubMed ID: 30187136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chronic hyperinsulinemia contributes to insulin resistance under dietary restriction in association with altered lipid metabolism in Zucker diabetic fatty rats.
    Morita I; Tanimoto K; Akiyama N; Naya N; Fujieda K; Iwasaki T; Yukioka H
    Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E264-E272. PubMed ID: 28143857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic glucose cycling does not contribute to the development of hyperglycemia in Zucker diabetic fatty rats.
    Henly DC; Chauvet MC; Phillips JW
    Diabetes; 1999 Feb; 48(2):342-6. PubMed ID: 10334311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats.
    Chabowski A; Chatham JC; Tandon NN; Calles-Escandon J; Glatz JF; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E675-82. PubMed ID: 16684853
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models.
    Etgen GJ; Oldham BA; Johnson WT; Broderick CL; Montrose CR; Brozinick JT; Misener EA; Bean JS; Bensch WR; Brooks DA; Shuker AJ; Rito CJ; McCarthy JR; Ardecky RJ; Tyhonas JS; Dana SL; Bilakovics JM; Paterniti JR; Ogilvie KM; Liu S; Kauffman RF
    Diabetes; 2002 Apr; 51(4):1083-7. PubMed ID: 11916929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intermittent protein restriction improves glucose homeostasis in Zucker diabetic fatty rats and single-cell sequencing reveals distinct changes in β cells.
    Li C; Zhu J; Wei S; Ye X; Yang L; Wang Z; Chen Y
    J Nutr Biochem; 2023 Apr; 114():109275. PubMed ID: 36669706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of apoptosis in failure of beta-cell mass compensation for insulin resistance and beta-cell defects in the male Zucker diabetic fatty rat.
    Pick A; Clark J; Kubstrup C; Levisetti M; Pugh W; Bonner-Weir S; Polonsky KS
    Diabetes; 1998 Mar; 47(3):358-64. PubMed ID: 9519740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.